Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Tarceva

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tarceva was produced by Roche and Astellas.

Daily Brief: Tagrisso's first line approval, EULAR and EHA, and why Stephen Hawking was wrong on NHS

Daily Brief: Tagrisso's first line approval, EULAR and EHA, and why Stephen Hawking was wrong on NHS head-to-head with existing EGFR drugs, Roche’s Tarceva and AstraZeneca’s own Iressa.

CHMP backs first-line use for AZ’s Tagrisso in lung cancer

CHMP backs first-line use for AZ’s Tagrisso in lung cancer comparator EGFR inhibitors including Roche’s Tarceva (erlotinib) or AZ’s earlier-generation EGFR drug Iressa (gefitinib).

AZ’s immuno-oncology combo fails another lung cancer trial

AZ’s immuno-oncology combo fails another lung cancer trial months for patients treated with Tagrisso, compared to 13.8 months for those on Roche’s Tarceva (erlotinib) or AZ’s earlier-generation EGFR drug Iressa (gefitinib).

AZ makes case for first-line Tagrisso therapy in lung cancer

AZ makes case for first-line Tagrisso therapy in lung cancer Data shows the drug improved PFS versus older EGFR inhibitors including Roche’s Tarceva. ... Earlier data from FLAURA have shown that AZ’s drug improved progression-free survival (PFS) versus older EGFR inhibitors erlotinib (Roche’s Tarceva) and

Reviews start for Pfizer’s wildcard lung cancer drug dacomitinib

Reviews start for Pfizer’s wildcard lung cancer drug dacomitinib line EGFR-mutated NSCLC market with Iressa and Roche's Tarceva (erlotinib), another first-generation drug, as well as newer agents like Boehringer Ingelheim’s Giotrif (afatinib).

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....
Success breeds success
This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
Turning learning into action: The challenge of behaviour change
...

Infographics